All News

Psoriasis Severe legs sara

Differences in Biologic Persistence in Psoriasis and Psoriatic Arthritis

d Jack Cush, MD

Administrative claims analysis of biologic use in psoriasis (PsO) and psoriatic arthritis (PsA) in French health insurance databases shows that despite widespread biologic use, overall drug persistence (beyond 3 years) was low for PsO and PsA biologics.

Read Article
alopecia,areata,bald,hairloss

Baricitinib Efficacy in Alopecia Areata

d Jack Cush, MD

The NEJM has published the results of the BRAVE-AA1 and BRAVE-AA2 trials, demonstrating that baricitinib is effective at regrowing hair in alopecia areata (AA) patients, thus paving the way for future regulatory approval for this difficult to treat disorder. 

Read Article
RheumNow Podcast square

Lupus Worries (3-25-22)

d Jack Cush, MD

Dr. Jack Cush Reviews the news and journal reports from the past week in RheumNow.com.

Read Article
gout.hand_.jpg

Comorbidity Drives Risk of Death in Gout Patients

d Jack Cush, MD

A study of men with gout from the US Veteran’s Health Administration (VHA) shows that excess mortality in gout could be attributed to comorbidities.

Read Article
CV,risk,MI,heart,cardiac

Stable Low Risk of Acute Coronary Syndrome in RA

d Jack Cush, MD

A Nordic multinational collaborative study examined the risk of acute coronary syndrome (ACS) in rheumatoid arthritis and found a less than 2 fold increased risk of ACS patients initiating biologic disease-modifying antirheumatic drugs (bDMARDs) with little risk variation with short-ter

Read Article
Mark your calendars! RheumNow is covering PsA this April. That means more Therapeutic Updates, Tuesday Night Rheumatology, Expert Blogs, and more. Join us April 1-30. https://t.co/b6OgsR8uxL
Dr. John Cush RheumNow ( View Tweet)
A case–control study from Kaiser, compared obstetric complications in women who later developed Systemic Sclerosis (n=17) vs non-SSc controls (170). Obstetric complications higher in later SSc (71 v 50%) (HTN, PROM, IUGR, NICU, preterm births) https://t.co/4Y4eGuCFJi https://t.co/R4vw90bba4

Links:

Dr. John Cush RheumNow ( View Tweet)
Infection in lupus is suggested by very high CRP, PMN-lymph ratio (NLR) Plt-lymph ratio(PLR). Study of 104 hospitalized SLE found all very high w/ infx & Combined cutoffs of CRP >20 mg/L, NLR >3.5, PLR >151 had 87 sensitivity & 81% specificity for infx https://t.co/5SjFsrBiZp https://t.co/0Ipussd9fF

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Montreal General Hosp SLE cohort study of 489 SLE pts - 35% have Raynauds phenomena; RP in SLE assoc. w/ Female (OR 2.43), White (OR 1.85), CNS disease (OR 1.98), RNP Abs (OR 3.0); negatively assoc w/ hemolytic anemia & cellular casts https://t.co/5t3GL4jqrm https://t.co/gVVqccvtca

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Environmental Pollutants Ups Autoimmune Disease Risk An Italian environmental study shows that air pollution increases the risk of autoimmune diseases, in particular rheumatoid arthritis, CTDs and inflammatory bowel diseases (IBD). https://t.co/oKdgSZ2jAF https://t.co/WI7aShKR97

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast available on Lupus worries. Download wherever you get your podcasts. https://t.co/gU1mmRXYUi https://t.co/54IDshqNYd

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Effect of Intraarticular Steroid Shots on Knee OA Outcomes In patients w/ OA of the knee, intra-articular injections of steroids didn’t increase rates of either disease progression or subsequent knee replacement surgery, researchers said. https://t.co/qinnfFLsGQ https://t.co/6859pSNNhL

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Drugs for Pregnancy Hopefuls A Young Woman has uncontrolled RA, but wants to get pregnant. What do you chose? https://t.co/Sunx8RWRfM https://t.co/hsFNhVfwHd

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Adalimumab Addition vs. Methotrexate Escalation in Psoriatic Arthritis https://t.co/q0uIjLrT3G https://t.co/ehgEUSrbPg

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Swedish study found 1774 systemic sclerosis (SSc) pts in 2015 w/ median age 65 yrs (84% women) = prevalence=22.7 per 100,000 . Incidence (2004-2015) was 11.9 per 1,000,000 PYs - incidence remained stable; F were 5x more common than M. https://t.co/NPZUg4CEjA https://t.co/V3H381KpHU

Links:

Dr. John Cush RheumNow ( View Tweet)
Ask Cush Anything! Have a rheumatology question or case for Dr. Cush? Submit it here and we may feature it on an upcoming podcast. https://t.co/KgPIeScthr https://t.co/nk4re9mlcH

Links:

Dr. John Cush RheumNow ( View Tweet)
High disease trajectory despite disease control (^HAQ > DAS28) in RA is more likely with higher pain, fatigue & depression. 10 ys study of 2500 RA pts from NOAR, ESPOIR, ERAN) https://t.co/mrB7fog6PD https://t.co/tqm3LPkOdM

Links:

Dr. John Cush RheumNow ( View Tweet)
98 axial SpA women with 335 pregnancies (279 live births) shows preterm birth ( (12.5 v 5.2%), preeclampsia(6.8 v 2.8%) & LBW (8.2 v 2.9%) more prevalent in axSpA, possibly due to incr disease activity during pregnancy & postpartum https://t.co/Bp8QjBXg2K https://t.co/j0xKVvSPIH

Links:

Dr. John Cush RheumNow ( View Tweet)
TENS does not work! Multi-centre, trial in 220 active Knee OA pts pitted TENS vs placebo TENS for 3 Wks. Using WOMAC pain scores there was no difference between TENS and placebo TENS (mean diff -0.06; P=0.74). No diff in AE or 2ndary outcomes https://t.co/4Aw9s1zfBQ https://t.co/gwdK6nbKLB

Links:

Dr. John Cush RheumNow ( View Tweet)
Poor Outcomes in Lupus Patients Not at Target A prospective, longitudinal SLE cohort study examined outcomes and showed that failure to control SLE was common/associated with poorer outcomes including organ damage, glucocorticoid exposure, and more. https://t.co/wQMmPgbmWF https://t.co/ROeZU56cfy

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×